MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,084 | +12.3% | 206 | +77.6% | 0.00% | – |
Q2 2023 | $26,796 | +46910.5% | 116 | -50.8% | 0.00% | – |
Q1 2023 | $57 | +103.6% | 236 | +145.8% | 0.00% | – |
Q4 2022 | $28 | -99.6% | 96 | 0.0% | 0.00% | – |
Q3 2022 | $7,000 | -53.3% | 96 | -54.9% | 0.00% | – |
Q2 2022 | $15,000 | -53.1% | 213 | -35.1% | 0.00% | – |
Q1 2022 | $32,000 | -68.6% | 328 | -81.5% | 0.00% | -100.0% |
Q4 2021 | $102,000 | -55.1% | 1,775 | -37.5% | 0.00% | 0.0% |
Q3 2021 | $227,000 | -18.1% | 2,842 | -0.1% | 0.00% | -50.0% |
Q2 2021 | $277,000 | -24.7% | 2,845 | -9.5% | 0.00% | 0.0% |
Q1 2021 | $368,000 | +5.1% | 3,145 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $350,000 | +22.0% | 3,145 | +30.1% | 0.00% | 0.0% |
Q3 2020 | $287,000 | -40.8% | 2,417 | -43.5% | 0.00% | -50.0% |
Q2 2020 | $485,000 | – | 4,281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |